ACRV — ACRIVON THERAPEUTICS INC
As of Q2 2026, 15 SEC-registered investment managers reported holding ACRV (ACRIVON THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $6.27M across 3.52M shares. That is +9.8% by share count (+315.69K shares) versus the previous quarter, while reported value moved +40.7%. Ownership is concentrated: the five largest holders account for 87.6% of reported value and the top ten for 99.2%.
Compared with the prior quarter, 3 opened new positions, 6 added to existing stakes, 4 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ACRV is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 698.86K | $1.68M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 888.13K | $1.58M | 0.00% | Hold |
| Renaissance Technologies history | Q2 2026 | 758.86K | $1.35M | 0.00% | Hold |
| Two Sigma Investments history | Q2 2026 | 641.50K | $1.14M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 531.86K | $946.70K | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 265.24K | $472.27K | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 239.11K | $425.62K | 0.00% | Add |
| Millennium Management history | Q4 2025 | 121.52K | $292.87K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q4 2023 | 31.94K | $157.14K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 67.20K | $119.62K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 43.85K | $78.05K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2025 | 63.64K | $75.73K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 41.28K | $73.47K | 0.00% | New |
| Invesco Ltd history | Q1 2025 | 35.31K | $71.69K | 0.00% | New |
| BNY Mellon history | Q1 2025 | 27.64K | $56.10K | 0.00% | Hold |
| Bank of America Corp history | Q2 2026 | 16.41K | $29.20K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 14.92K | $26.56K | 0.00% | Add |
| AQR Capital Management history | Q2 2025 | 22.25K | $26.48K | 0.00% | New |
| Point72 Asset Management history | Q4 2025 | 10.88K | $26.21K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 6.96K | $12.38K | 0.00% | Reduce |
New Positions (Q2 2026)
- Citadel Advisors 41.28K sh · $73.47K
- JPMorgan Chase & Co 751 sh · $1.34K
- Citigroup Inc 6 sh · $11
Fully Exited (vs previous quarter)
- Wells Fargo & Co sold 3.00K sh · $4.17K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellington Management Group | 900.15K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K | 888.13K |
| Renaissance Technologies | — | — | — | — | — | 102.60K | 54.50K | 45.90K | 49.40K | 52.10K | 509.30K | 623.40K | 634.17K | 758.44K | 758.86K |
| Two Sigma Investments | 21.53K | — | — | — | — | — | — | — | — | — | 181.17K | 319.20K | 585.07K | 389.39K | 641.50K |
| Marshall Wace | 1.22M | 597.47K | 597.47K | 597.47K | 597.47K | 597.47K | 948.87K | 809.86K | 597.79K | 450.39K | 181.19K | 149.72K | 496.08K | 560.44K | 531.86K |
| Geode Capital Management | — | 175.40K | 178.45K | 189.56K | 189.20K | 242.85K | 308.39K | 302.10K | 301.39K | 306.11K | 164.36K | 192.03K | 198.22K | 236.39K | 265.24K |
| BlackRock Inc | — | — | — | — | — | — | — | 786.98K | 945.50K | 938.71K | 407.62K | 330.96K | 205.12K | 208.94K | 239.11K |
| Northern Trust Corp | — | 69.75K | 68.68K | 72.72K | 80.15K | 107.75K | 114.05K | 105.40K | 117.32K | 109.03K | 46.78K | 42.17K | 63.72K | 48.90K | 67.20K |
| UBS Group AG | 4.75K | 5.40K | 9.78K | 102 | — | 12.74K | 11.15K | 5.66K | 14.22K | 12.89K | 455 | 683.22K | 348.54K | 34.63K | 43.85K |
| Citadel Advisors | 1.63M | 1.64M | 1.65M | 1.65M | 1.65M | 1.68M | 2.12M | 2.14M | 2.12M | 1.90M | 1.90M | 1.54M | 1.64M | — | 41.28K |
| Bank of America Corp | — | 5.86K | 7.62K | 9.33K | 10.09K | 6.04K | 27.55K | 29.96K | 31.11K | 27.70K | 20.62K | 18.90K | 17.45K | 16.51K | 16.41K |
| Goldman Sachs Group | 38.80K | 13.72K | — | — | — | — | 24.38K | 198.17K | 237.55K | 57.52K | 140.06K | 19.74K | 119.42K | 14.74K | 14.92K |
| Fidelity Management & Research (FMR) | — | 122 | 422 | 288 | 806 | 1.03K | 1.65K | 2.58K | 2.93K | 2.67K | 9.85K | 8.62K | 8.62K | 9.42K | 6.96K |
| Morgan Stanley | 869 | 5.62K | 8.51K | 4.94K | 25.63K | 17.24K | 17.25K | 35.91K | 34.73K | 35.22K | 63.02K | 57.16K | 46.83K | 36.67K | 5.23K |
| JPMorgan Chase & Co | — | — | 6.93K | 26.57K | 33.34K | 4.96K | 5.24K | 33.99K | 25.81K | 8.48K | 1.42K | 1.74K | 16.86K | — | 751 |
| Citigroup Inc | — | 202 | 2.79K | 230 | 2.05K | 4.54K | 5.08K | 11.22K | 12.33K | 11.16K | 32.38K | 16.30K | 14.59K | — | 6 |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | 10.88K | — | — |
| Millennium Management | 19.64K | — | — | — | — | 95.50K | — | 39.75K | — | — | 296.24K | 185.23K | 121.52K | — | — |
| Vanguard Group | — | 409.21K | 403.27K | 468.41K | 475.98K | 507.19K | 745.51K | 637.54K | 671.62K | 674.79K | 593.25K | 626.15K | 698.86K | — | — |
| Wells Fargo & Co | — | 1.59K | 3.31K | 2.16K | 2.69K | 4.30K | 5.19K | 5.42K | 6.93K | 7.09K | 141 | — | — | 3.00K | — |
| Deutsche Bank AG | — | 5.37K | 4.06K | — | — | — | — | — | — | 541 | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details